1
|
Puente N, Solis P, Riancho JA. Genetic causes of hypophosphatemia. Minerva Med 2024; 115:320-336. [PMID: 38727708 DOI: 10.23736/s0026-4806.24.09198-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/21/2024]
Abstract
Phosphate is a key component of mineralized tissues and is also part of many organic compounds. Phosphorus homeostasis depends especially upon intestinal absorption, and renal excretion, which are regulated by various hormones, such as PTH, 1,25-dihydroxyvitamin D, and fibroblast growth factor 23. In this review we provide an update of several genetic disorders that affect phosphate transporters through cell membranes or the phosphate-regulating hormones, and, consequently, result in hypophosphatemia.
Collapse
Affiliation(s)
- Nuria Puente
- Service of Internal Medicine, Hospital U. M. Valdecilla, University of Cantabria, Santander, Spain
- Department of Medicine and Psychiatry, University of Cantabria, Santander, Spain
- Valdecilla Research Institute, Santander, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, ISCIII), Madrid, Spain
| | - Pablo Solis
- Service of Internal Medicine, Hospital U. M. Valdecilla, University of Cantabria, Santander, Spain
| | - Jose A Riancho
- Service of Internal Medicine, Hospital U. M. Valdecilla, University of Cantabria, Santander, Spain -
- Department of Medicine and Psychiatry, University of Cantabria, Santander, Spain
- Valdecilla Research Institute, Santander, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, ISCIII), Madrid, Spain
| |
Collapse
|
2
|
Cueto-Robledo G, Cantero-Ceballos MDC, Gonzalez-Hermosillo LM, Navarro-Vergara DI, Garcia-Cesar M, Torres-Rojas MB, Hernandez-Villa L, Serrato BG, Alfaro-Cruz A. Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review. Curr Probl Cardiol 2024; 49:102453. [PMID: 38342349 DOI: 10.1016/j.cpcardiol.2024.102453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Accepted: 02/08/2024] [Indexed: 02/13/2024]
Abstract
This review focuses on Pulmonary Alveolar Microlithiasis (PAM), an autosomal recessive genetic disorder characterized by calcium crystal deposits (microliths) resulting from loss of function of the SLC34A2 gene. PAM is a rare disease with approximately 1100 reported cases globally. The historical context of its discovery and the genetic, epidemiological, and pathophysiological aspects are discussed. PAM falls under interstitial lung diseases and is associated with pulmonary hypertension (PH), primarily categorized as Group 3 PH. The clinical manifestations, diagnostic approaches, and challenging aspects of treatment are explored. A clinical case of PAM with severe pulmonary hypertension is presented, emphasizing the importance of comprehensive evaluation and the potential benefits of phosphodiesterase-5 inhibitors (PDE5i) therapy. Despite limited therapeutic options and challenging diagnosis, this review sheds light on recent developments and emerging treatments for PAM and associated pulmonary hypertension.
Collapse
Affiliation(s)
- Guillermo Cueto-Robledo
- Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico; Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
| | | | | | - Dulce-Iliana Navarro-Vergara
- Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| | - Marisol Garcia-Cesar
- Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| | - Maria-Berenice Torres-Rojas
- Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| | - Lizbeth Hernandez-Villa
- Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| | - Brenda-Guadalupe Serrato
- Pneumology Department, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| | - Ana Alfaro-Cruz
- Pathological Anatomy Department, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico
| |
Collapse
|
3
|
Liu Q, Ju X, Guo T, Peng H. A novel compound heterozygous mutation in the SLC34A2 gene causes pulmonary alveolar microlithiasis. QJM 2024; 117:293-296. [PMID: 38070491 DOI: 10.1093/qjmed/hcad280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Indexed: 04/14/2024] Open
Affiliation(s)
- Qingqing Liu
- Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
- Research Unit of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
- Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha, Hunan 410011, China
- Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
| | - Xiaoqin Ju
- Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
- Research Unit of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
- Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha, Hunan 410011, China
- Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
| | - Ting Guo
- Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
- Research Unit of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
- Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha, Hunan 410011, China
- Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
| | - Hong Peng
- Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
- Research Unit of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
- Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha, Hunan 410011, China
- Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan 410011, China
| |
Collapse
|
4
|
Lee JB, Nagasaka M. Translational Research in ROS1-Positive NSCLC: Are We Moving Out of the Six Blind Men and the Elephant Stage? J Thorac Oncol 2024; 19:525-527. [PMID: 38582542 DOI: 10.1016/j.jtho.2024.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Accepted: 01/10/2024] [Indexed: 04/08/2024]
Affiliation(s)
- Jii Bum Lee
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
| | - Misako Nagasaka
- Division of Hematology-Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California; Chao Family Comprehensive Cancer Center, Orange, California
| |
Collapse
|